Stem Cell Research in Japan

Stem Cell Research and News: Japan

Bone Marrow Derived Stem Cells Investigated For Stroke Therapy

Stem cell researchers in Japan investigating bone marrow stromal cells may have discoverd how to restore lost neurologic function when transplanted into animals exhibiting central nervous system disorders. "Our study showed that cell transplantation therapy may improve brain receptor function...

Posted in Today's Stem Cell Research on March 17, 2006 01:28 PM

ViaCell Reports Success With Heart Treatment Stem Cell Therapy

Well known stem cell research firm ViaCell is reporting that Unrestricted Somatic Stem Cells (USSCs), which are pluripotent stem cells and can be collected human cord blood, have been tested in a small animal model of myocardial infarction .. ie...

Posted in Today's Stem Cell Research on March 14, 2006 02:58 PM

Stem Cells from Menstral Blood? .. Yep ..

Stem cell researchers in Japan have found that stem cells can actually be harvested from human menstrual blood. Sure enough, the stem cells are sound very much like hematopoietic stem cells in that they can differentiate into specialised heart cells....

Posted in Today's Stem Cell Research on March 14, 2006 02:47 PM

Fast Growing Stem Cells Found In Wisdom Teeth

It was quite a long time ago since we looked at stem cells and teeth. The focus here is a little different as these stem cells derived from cells within teeth are being used to differentiate into either bone or...

Posted in Today's Stem Cell Research on March 10, 2006 11:48 PM

ThermoGenesis Corp. Announces Fourth Quarter and Year End Results

Three (3) Essential Milestones Completed for the Company: AXP Development, Completion of CryoSeal US Pivotal Trial Enrollment and TPD European Launch RANCHO CORDOVA, Calif., Sept. 9, 2005 - ThermoGenesis Corp. (NASDAQ-SCM: KOOL) today announced results for its fourth quarter and...

Posted in Today's Stem Cell Research on September 9, 2005 04:07 PM

Stem Cells Found in Heart Tissue

With all the news as of late with Katrina and the like .. we have been hard pressed to keep on top of other developments. However, as we pray for the survivors and hope the best for all those affected,...

Posted in Today's Stem Cell Research on September 9, 2005 03:03 PM

International Stem Cell Meeting in Kobe, Japan

Asian, European and American scientists participate in high-level workshop on "Stem Cells in Reproduction and in the Brain" A critical mass of leading experts will meet from 1st to 3rd September in Kobe, Japan, to discuss and summarize the current...

Posted in Today's Stem Cell Research on September 2, 2005 05:37 PM

Cytori Therapeutics Presents at Cell-Based Regenerative Medicine Symposium: Road to Clinical Applications

Conference Hosted by Healthcare Policy Institute, Japan SAN DIEGO & TOKYO, Aug. 17, 2005 - Cytori Therapeutics, Inc. (Frankfurt:XMP), a global biotechnology company innovating regenerative medicine, announced today that Marc H. Hedrick, M.D., President for Cytori Therapeutics, is an invited...

Posted in Today's Stem Cell Research on August 18, 2005 06:36 PM

Osiris and JCR Pharmaceuticals Reach Milestone, Expand License Agreement

Companies to expand stem cell technology into a new market opportunity BALTIMORE, Maryland August 4, 2005 - Osiris Therapeutics, Inc. announced today that it has expanded the terms of its license agreement with JCR Pharmaceuticals Co. Ltd. of Ashiya, Japan,...

Posted in Today's Stem Cell Research on August 5, 2005 06:43 PM

StemCyte, Inc. Completes Significant Round of Financing

Leader in Stem Cell Technology Adds New Investors ARCADIA, Calif., July 19 /PRNewswire/ - StemCyte®, Inc., a leading umbilical cord blood stem cell transplantation and therapeutic products company, today announced it has recently completed a significant round of financing from...

Posted in Today's Stem Cell Research on July 26, 2005 01:55 PM

Thermogenesis Corp. Completes Enrollment Of 150-Patient Human Clinical Trial Of CRYOSEAL® Fibrin Sealant System

RANCHO CORDOVA, California (June 22, 2005) – ThermoGenesis Corp. (NASDAQ: KOOL) announced today that enrollment is now complete for its pivotal U.S. 150-patient blinded, randomized, multi-center clinical trial for the CryoSeal Fibrin Sealant (FS) System. This pivotal trial evaluated the...

Posted in Today's Stem Cell Research on July 12, 2005 11:33 AM

MacroPore Biosurgery, Inc. Changes Name to Cytori Therapeutics, Inc.

San Diego, CA, July 11, 2005 - MacroPore Biosurgery, Inc. (Frankfurt: XMP) today announced it has changed its name to Cytori Therapeutics, Inc. The change was made to better reflect the company's focus and significant progress in the development of...

Posted in Today's Stem Cell Research on July 11, 2005 11:41 PM

Cambridge To Be New HQ for Scottish Stem Cell Company

Cambridge is to become the UK headquarters and a key hub in a global growth strategy for a Scottish stem cell company that will float on AIM in the next fortnight. Stem Cell Sciences in Edinburgh will use some of...

Posted in Today's Stem Cell Research on June 29, 2005 01:37 AM

New Investment Report Reveals Rapid Growth of Stem Cell Technology Research

Investment into stem cell technology is continuing apace despite public controversy and legal and regulatory barriers, according to a report by Marks & Clerk, one of the world’s leading firms of patent and trade mark attorneys. In its Biotechnology Report...

Posted in Today's Stem Cell Research on June 23, 2005 02:18 PM

Celgene's Revlimid Will Generate $321 Million in Sales for the Multiple Myeloma Drug Market in 2009

WALTHAM, Mass., June 22, 2005 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and health care issues, forecasts that sales of Celgene's Revlimid, an oral immunomodulatory agent for the treatment of...

Posted in Today's Stem Cell Research on June 22, 2005 06:00 PM

Stem Cell Research Company In Scotland Targetting July, 10 IPO

A stem cell research firm based in Scotland is trying to raise 10 million pounds ($18.3 million) by posting to London's junior stock market next month to help fund new research. Stem Cell Sciences Plc stated that it plans to...

Posted in Today's Stem Cell Research on June 22, 2005 05:59 PM

MultiCell Technologies and XenoTech LLC Jointly Announce Shrink Wrap Vial Sales Launch for Immortalized Hepatocytes

New Procedure Expected to Speed Adoption Through Reduced Sales Cycle LINCOLN, R.I. – (BUSINESS WIRE) – June 15, 2005 – MultiCell Technologies, Inc. (OTCBB: MCET), a leading supplier of immortalized non-tumorgenic human hepatocytes as pharmaceutical candidate optimization tools, announced sales...

Posted in Today's Stem Cell Research on June 16, 2005 11:58 PM

Two New Studies in the British Journal of Haematology Show Potential Role of VELCADE® (Bortezomib) for Injection in Treating Patients with Front-Line Multiple Myeloma

High Complete and Near Complete Response Rates Achieved Alone and in Combination; Subsequent Stem Cell Harvest and Transplants Successful CAMBRIDGE, Mass., June 8 -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced publication in The British Journal of Haematology of two...

Posted in Today's Stem Cell Research on June 14, 2005 08:42 PM

MultiCell and XenoTech to Exhibit Immortalized Hepatocytes at New European Exhibition

LINCOLN, R.I.--(BUSINESS WIRE)--Jun 9, 2005 - MultiCell Technologies, Inc. (OTCBB: MCET) a leading supplier of immortalized human hepatic cell lines for pharmaceutical candidate optimization, announced today that it will attend the inaugural Pharmaceutical Sciences Fair and Exhibition in Nice, France,...

Posted in Today's Stem Cell Research on June 9, 2005 08:43 PM

StemCo Biomedical Signs Worldwide Distribution Deal for ALDEFLUOR with StemCell Technologies

DURHAM, North Carolina -- Jun 9, 2005 - StemCo Biomedical, Inc. today announced that it has signed a worldwide distribution agreement whereby StemCell Technologies will distribute StemCo's ALDEFLUOR(TM) product. StemCell Technologies had previously distributed ALDEFLUOR only in the Americas and...

Posted in Today's Stem Cell Research on June 9, 2005 08:37 PM

Cytori Therapeutics, Inc. Corp. Sheet

Cytori Therapeutics, Inc. Articles More Cytori Therapeutics / MacroPore Biosurgery, Inc. Articles Corporate Summary (site quote): Cytori Therapeutics is discovering and developing proprietary, cell-based therapeutics utilizing adult stem cells derived from adipose, also known as fat tissue....

Posted in Today's Stem Cell Research on May 8, 2005 02:43 PM

Stem Cell Research, Policy Implications Showcased at BIO 2005

WASHINGTON, D.C. (April 27, 2005) -- A series of thought-provoking, educational panel sessions on varying aspects of stem cell research will be showcased at the BIO 2005 Annual International Convention, June 19-22, 2005, at the Pennsylvania Convention Center in Philadelphia....

Posted in Today's Stem Cell Research on May 3, 2005 03:37 PM

Stem Cell Research In The Czech Republic

Doctor Petr Dvorak in Brno, Czech Republic heads a team of 12 scientists and technicians who are working with embryonic stem cells from mice and humans. It's in his sterile lab where human embryonic stem cells are being cultured in...

Posted in Today's Stem Cell Research on April 21, 2005 10:20 PM

Stem Cell Sciences (STEM) Corp. Sheet

Stem Cell Sciences Corporation Articles More Stem Cell Sciences Corporation Articles Corporate Summary (site quote): Stem Cell Sciences (SCS) is an international company with centres in the United Kingdom, Australia and Japan....

Posted in Today's Stem Cell Research on April 21, 2005 08:35 PM

Islet Cell Implant From Mother Cures Diatebetes In Woman

This is a bit off topic, but as we know in the focus of stem cell research, this kind of news will be affected .. hopefully in the near term. Slashdot is discussing an announcment from Kyoto, Japan, where a...

Posted in Today's Stem Cell Research on April 20, 2005 12:12 PM

Dr. Stephen Chang, President of MultiCell Technologies Inc., Talks to The Wall Street Transcript

NEW YORK--(BUSINESS WIRE)--April 19, 2005--The Wall Street Transcript has published an in-depth interview with Dr. Stephen Chang, President of MultiCell Technologies Inc. (OTCBB:MUCL) in which he talks at length about the Company....

Posted in Today's Stem Cell Research on April 19, 2005 07:14 PM

ThermoGenesis Corp. to Present at SunTrust Robinson Humphrey's Annual Conference

RANCHO CORDOVA, Calif., April 11 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a pioneer in the development of systems that enable the production and storage of therapeutic components, today announced that Chairman and Chief Executive Officer, Philip H. Coelho, will be...

Posted in Today's Stem Cell Research on April 11, 2005 03:27 PM

OffTopic .. Only a Little .. Inkjet Nozzles To Spray Live Human Cells Onto Patients?

Scientists at the University of Manchester in England working to develop a technique in which inkjet nozzles spray live human cells onto a patient. This methodology could speed up a patient's healing process because doctors could "spray" on replacement tissue...

Posted in Today's Stem Cell Research on April 7, 2005 12:47 AM

ThermoGenesis Corp. to Supply Autologous Thrombin Kits to Biomet, Inc.

RANCHO CORDOVA, Calif., April 5 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL - News) announced today that the Company and Biomet, Inc (Nasdaq: BMET - News) reached agreement for the Company to supply Biomet's subsidiary, Cell Factor Technologies, Inc. (CFT) with...

Posted in Today's Stem Cell Research on April 5, 2005 09:46 PM

Asahi Kasei Medical and ThermoGenesis also expand distribution agreement

RANCHO CORDOVA, Calif., March 28 /PRNewswire-FirstCall/ -- THERMOGENESIS CORP. (Nasdaq: KOOL - News) announced today that Asahi Kasei Medical Co., Ltd. (Asahi), a premier supplier of medical products and disposables and the exclusive licensed distributor of the CryoSeal System in...

Posted in Today's Stem Cell Research on March 28, 2005 07:56 PM

Mycamine Received FDA Approval - Fujisawa Healthcare, Inc.’s Echinocandin To Fight Candida Fungal Infections From Stem Cell Transplant

Fujisawa Healthcare, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the use of micafungin sodium, the antifungal product for prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation and the treatment of esophageal...

Posted in Today's Stem Cell Research on March 20, 2005 11:36 PM

Correction -- ThermoGenesis Corp. Requests the U.S. Patent Office to Re-Examine Two Additional PharmaStem Cord Blood Stem Cell Patents

RANCHO CORDOVA, Calif., March 8 /PRNewswire-FirstCall/ -- THERMOGENESIS CORP. (Nasdaq: KOOL) a manufacturer of sophisticated Cryogenic Systems for Cord Blood Banks today announced that it has requested that the United States Patent and Trademark Office ("PTO") re-examine patent No's 6,569,427...

Posted in Today's Stem Cell Research on March 9, 2005 02:31 PM

US Patent Office Rejects PharmaStem Cord Blood Stem Cell Patents

ThermoGenesis Corp. (Nasdaq: KOOL), a supplier of cryogenic devices used by cord blood banks, and NETCORD, the leading international network of public cord blood banks, today announced that the U.S. Patent Office (PTO) has reexamined U.S. Patent 5,192,553 (Patent '553)...

Posted in Today's Stem Cell Research on March 1, 2005 07:47 PM

Human Kidney Cloned In Rats From Bone Marrow Stem Cells

Researchers in Japan report that they have cloned a human kidney by cultivating human stem cells extracted from adult bone marrow into rat embryos. The development is expected to increase the likelyhood of expanding regenerative medicine to anatomically complicated organs...

Posted in Today's Stem Cell Research on February 23, 2005 02:42 PM

Michigan: Stem Cells and Gene Therapy To Treat Deafness

A new form of gene therapy has apparently cured deafness in guinea pigs. "It's the first time anyone has biologically repaired the hearing of animals," says Yehoash Raphael at the University of Michigan in Ann Arbor, Michigan, and head of...

Posted in Today's Stem Cell Research on February 17, 2005 01:42 PM

MultiCell Technologies Appoints Anthony Cataldo to Position of Non-Executive Co-Chairman

MultiCell Technologies, Inc. (OTCBB: MUCL), a leading supplier of functional non-tumorigenic immortalized human hepatocytes, announced today that it has appointed Anthony J. Cataldo to serve as Non-Executive Co-Chairman of the Board. In this role, Mr. Cataldo is expected to focus...

Posted in Today's Stem Cell Research on February 14, 2005 05:51 PM

Massachusetts: Cord Blood Banking Only Makes Sense if It's a Shared Effort

How much would you pay to guard your newborn against the future risk of fatal cancer, heart disease, immune problems, and many other serious diseases? Companies such as Cord Blood Registry, Boston-based Viacord, and about 20 others are betting that...

Posted in Today's Stem Cell Research on February 10, 2005 12:09 PM

ThermoGenesis Corp. (KOOL) Corp. Sheet

ThermoGenesis Corp. Articles More ThermoGenesis Corp. Articles Corporate Summary (site quote): ThermoGenesis Corp. is a leader in enabling technologies for cell therapeutics. The Company's technology platforms lead the world in their ability to produce biological products from single units...

Posted in Today's Stem Cell Research on January 21, 2005 03:54 PM

Stem Cell Technology could Treat Cancer

New stem cell technology developed jointly by Cambridge and Japanese researchers to blitz killer cancers is to be commercialised by an American company. Developed by Dr Toru Kondo, a neurobiologist at the Centre for Brain Repair at the University of...

Posted in Today's Stem Cell Research on January 21, 2005 03:43 PM

Today's Stem Cell Research

Stem Cell Research and News: Japan

Stem Cell Categories

Stem Cell Monthly